Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy"
Clin Mol Hepatol
.
2024 Oct;30(4):714-717.
doi: 10.3350/cmh.2024.0425.
Epub 2024 Jun 11.
Author
Paul Y Kwo
1
Affiliation
1
Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA.
PMID:
38858181
PMCID:
PMC11540391
DOI:
10.3350/cmh.2024.0425
No abstract available
Keywords:
Hepatitis C; Hepatocellular carcinoma; Metformin; Statin.
Publication types
Editorial
Comment